2022 annual financial data
Capricor Therapeutics, Inc. 2022 Operating margin
Capricor Therapeutics, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,163.93%.
Operating income was -29,697,383 USD and net income was -29,019,532 USD.
Operating cash flow was 4,916,637 USD.
Get free Capricor Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,551,469 USD
- Operating income
- -29,697,383 USD
- Net income
- -29,019,532 USD
- Operating cash flow
- 4,916,637 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Capricor Therapeutics, Inc. financial years